Alpine Immune Sciences to Participate in Fireside Chat at the Piper Sandler 32nd Annual Virtual Healthcare Conference

November 16, 2020

SEATTLE--(BUSINESS WIRE)--Nov. 16, 2020-- Alpine Immune Sciences, Inc. (NASDAQ:ALPN), a leading clinical-stage immunotherapy company focused on developing innovative treatments for cancer and autoimmune/inflammatory diseases, today announced the company will participate in a fireside chat at the Piper Sandler 32nd Annual Virtual Healthcare Conference.

The fireside chat will be available online during the week of November 23 in the investor relations section of the company’s website at https://ir.alpineimmunesciences.com/events. The virtual conference will be held from December 1-3, 2020.

About Alpine Immune Sciences, Inc. 

Alpine Immune Sciences, Inc. is committed to leading a new wave of immune therapeutics. With world-class research and development capabilities, a highly productive scientific platform, and a proven management team, Alpine is creating multifunctional immunotherapies via unique protein engineering technologies to improve patients’ lives. For more information, visit www.alpineimmunesciences.com. Follow @AlpineImmuneSci on Twitter and LinkedIn.

“Secreted Immunomodulatory Proteins”, “SIP”, “Transmembrane Immunomodulatory Protein,” “TIP,” “Variant Ig Domain,” “vIgD” and the Alpine logo are registered trademarks or trademarks of Alpine Immune Sciences, Inc. in various jurisdictions.

Paul Rickey
Chief Financial Officer
Alpine Immune Sciences, Inc.
206-788-4545
[email protected]

Laurence Watts
Managing Director
Gilmartin Group, LLC.
619-916-7620
[email protected]

Source: Alpine Immune Sciences Inc.